JP2023520916A5 - - Google Patents

Info

Publication number
JP2023520916A5
JP2023520916A5 JP2022561080A JP2022561080A JP2023520916A5 JP 2023520916 A5 JP2023520916 A5 JP 2023520916A5 JP 2022561080 A JP2022561080 A JP 2022561080A JP 2022561080 A JP2022561080 A JP 2022561080A JP 2023520916 A5 JP2023520916 A5 JP 2023520916A5
Authority
JP
Japan
Prior art keywords
formula
heteroaryl
alkyl
compound
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022561080A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023520916A (ja
JP7879597B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/026481 external-priority patent/WO2021207554A1/en
Publication of JP2023520916A publication Critical patent/JP2023520916A/ja
Publication of JP2023520916A5 publication Critical patent/JP2023520916A5/ja
Application granted granted Critical
Publication of JP7879597B2 publication Critical patent/JP7879597B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022561080A 2020-04-08 2021-04-08 スプライシングを調整するための化合物及び方法 Active JP7879597B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202063007331P 2020-04-08 2020-04-08
US63/007,331 2020-04-08
US202063044318P 2020-06-25 2020-06-25
US63/044,318 2020-06-25
US202063072922P 2020-08-31 2020-08-31
US63/072,922 2020-08-31
US202063126494P 2020-12-16 2020-12-16
US63/126,494 2020-12-16
PCT/US2021/026481 WO2021207554A1 (en) 2020-04-08 2021-04-08 Compounds and methods for modulating splicing

Publications (3)

Publication Number Publication Date
JP2023520916A JP2023520916A (ja) 2023-05-22
JP2023520916A5 true JP2023520916A5 (cg-RX-API-DMAC7.html) 2024-04-19
JP7879597B2 JP7879597B2 (ja) 2026-06-24

Family

ID=75690721

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022561080A Active JP7879597B2 (ja) 2020-04-08 2021-04-08 スプライシングを調整するための化合物及び方法

Country Status (15)

Country Link
US (2) US20230167093A1 (cg-RX-API-DMAC7.html)
EP (1) EP4132646A1 (cg-RX-API-DMAC7.html)
JP (1) JP7879597B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220167298A (cg-RX-API-DMAC7.html)
CN (1) CN115551593A (cg-RX-API-DMAC7.html)
AU (1) AU2021253587A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022020423A2 (cg-RX-API-DMAC7.html)
CA (1) CA3174353A1 (cg-RX-API-DMAC7.html)
CL (1) CL2022002780A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022015925A2 (cg-RX-API-DMAC7.html)
CR (1) CR20220566A (cg-RX-API-DMAC7.html)
IL (1) IL297137A (cg-RX-API-DMAC7.html)
MX (1) MX2022012678A (cg-RX-API-DMAC7.html)
TW (1) TWI912305B (cg-RX-API-DMAC7.html)
WO (2) WO2021207554A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020001425A (es) 2017-08-04 2020-08-06 Skyhawk Therapeutics Inc Metodos y composiciones para modular el empalme.
WO2020163248A1 (en) 2019-02-04 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
WO2020163541A1 (en) 2019-02-05 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
JP7603594B2 (ja) 2019-02-06 2024-12-20 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
IL297963A (en) 2020-05-07 2023-01-01 Adorx Therapeutics Ltd Antagonists of the adenosine a2a receptor
WO2021231571A1 (en) 2020-05-13 2021-11-18 Chdi Foundation, Inc. Htt modulators for treating huntington's disease
WO2022047145A1 (en) 2020-08-28 2022-03-03 Arvinas Operations, Inc. Rapidly accelerating fibrosarcoma protein degrading compounds and associated methods of use
US20250332173A1 (en) * 2021-10-13 2025-10-30 Remix Therapeutics Inc. Compounds and methods for modulating nucleic acid splicing
AU2022394333A1 (en) 2021-11-17 2024-06-27 Chdi Foundation, Inc. HTT modulators for treating Huntington’s disease
JP2024541481A (ja) * 2021-11-24 2024-11-08 リミックス セラピューティクス インコーポレイテッド スプライシングを調整するための化合物及び方法
US20250326748A1 (en) * 2022-01-05 2025-10-23 Remix Therapeutics Inc. Compounds and methods for modulating splicing
EP4584258A1 (en) 2022-09-07 2025-07-16 Arvinas Operations, Inc. Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use
CN116377059B (zh) * 2023-04-28 2026-05-15 华中科技大学同济医学院附属协和医院 Luc7l2在诊断和治疗急性肾损伤中的用途
WO2024259017A1 (en) * 2023-06-12 2024-12-19 Remix Therapeutics Inc. Compounds and methods for modulating splicing
CN120388720B (zh) * 2024-09-18 2026-02-17 大连医科大学附属第二医院 基于uqcc2与mettl3的计算机辅助筛选药物的方法、系统和设备

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0309765A3 (en) * 1987-09-30 1990-09-26 Fisons Corporation 1(2h)-phthalazinones as cytoprotective agents
DE60010448T2 (de) * 1999-03-17 2005-04-07 Astrazeneca Ab Amid-derivate
GB0324790D0 (en) * 2003-10-24 2003-11-26 Astrazeneca Ab Amide derivatives
TWI320783B (en) * 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
US20090069300A1 (en) * 2007-09-12 2009-03-12 Wyeth Isoquinolinyl and isoindolinyl derivatives as histamine-3 antagonists
UA111579C2 (uk) * 2009-08-17 2016-05-25 Інтеллікіне Ллк ГЕТЕРОЦИКЛІЧНІ ПОХІДНІ 2-АМІНОБЕНЗО[d]ОКСАЗОЛУ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА ЇХ ЗАСТОСУВАННЯ ДЛЯ ЛІКУВАННЯ ЗАХВОРЮВАННЯ, ПОВ'АНОГО З РІ3-КІНАЗОЮ
EP3406252B1 (en) 2012-02-10 2020-05-13 PTC Therapeutics, Inc. Compounds for treating spinal muscular atrophy
US8729263B2 (en) 2012-08-13 2014-05-20 Novartis Ag 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
HK1219421A1 (zh) * 2013-03-15 2017-04-07 因特利凯有限责任公司 激酶抑制剂的组合及其用途
EP3256126B1 (en) 2015-02-09 2024-03-27 F. Hoffmann-La Roche AG Compounds for the treatment of cancer
MA41898A (fr) * 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
EP3310169B1 (en) 2015-05-30 2023-05-17 PTC Therapeutics, Inc. Methods for modulating rna splicing
WO2017050865A1 (en) * 2015-09-23 2017-03-30 Janssen Pharmaceutica Nv Bi-heteroaryl substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
CA3119019C (en) 2015-12-10 2024-06-11 Ptc Therapeutics, Inc. Compounds and methods for treating huntington's disease
RS63116B1 (sr) * 2016-05-06 2022-05-31 Shanghai De Novo Pharmatech Co Ltd Derivat benzazepina, postupak za dobijanje, farmaceutska kompozicija i njegova upotreba
US10913730B2 (en) * 2016-10-10 2021-02-09 Dong-A Socio Holdings Co., Ltd. Heteroaryl compounds and their use as Mer inhibitors
JP2019535789A (ja) 2016-11-28 2019-12-12 ピーティーシー セラピューティクス,インコーポレーテッド Rnaスプライシングを調節する方法
US11590167B2 (en) * 2016-12-03 2023-02-28 Juno Therapeutic, Inc. Methods and compositions for use of therapeutic T cells in combination with kinase inhibitors
WO2018133865A1 (zh) * 2017-01-22 2018-07-26 福建广生堂药业股份有限公司 Ask1抑制剂及其制备方法和应用
CN108658990B (zh) * 2017-03-31 2021-03-23 南京科技职业学院 一类新型咪唑并[1,5-a]吡嗪类布鲁顿激酶抑制剂
CN111372611A (zh) 2017-06-14 2020-07-03 Ptc医疗公司 修饰rna剪接的方法
MX2020001425A (es) 2017-08-04 2020-08-06 Skyhawk Therapeutics Inc Metodos y composiciones para modular el empalme.
US20230152257A1 (en) 2017-09-25 2023-05-18 Skyhawk Therapeutics, Inc. Methods and compositions for screening and identification of splicing
CN109721597B (zh) * 2017-10-30 2021-05-14 上海迪诺医药科技有限公司 吡啶并氮杂卓衍生物、其药物组合物及应用
WO2019094312A1 (en) * 2017-11-08 2019-05-16 Merck Sharp & Dohme Corp. Prmt5 inhibitors
WO2019105886A1 (en) * 2017-12-02 2019-06-06 Galapagos Nv Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
JP2021521200A (ja) 2018-04-10 2021-08-26 スカイホーク・セラピューティクス・インコーポレーテッド 癌の処置のための化合物
WO2020004594A1 (ja) * 2018-06-27 2020-01-02 株式会社リボルナバイオサイエンス 脊髄性筋萎縮症の予防または治療剤
KR20230024328A (ko) * 2020-06-12 2023-02-20 상하이 제민케어 파마슈티칼스 컴퍼니 리미티드 프탈라지논 화합물, 이의 제조 방법 및 이의 의학적 용도

Similar Documents

Publication Publication Date Title
JP2023515621A5 (cg-RX-API-DMAC7.html)
JP2023515617A5 (cg-RX-API-DMAC7.html)
JP2023520924A5 (cg-RX-API-DMAC7.html)
JP2023515618A5 (cg-RX-API-DMAC7.html)
JP2023515620A5 (cg-RX-API-DMAC7.html)
CN111263767B (zh) 作为干扰素基因调节剂的刺激剂的环状二核苷酸
IL295957A (en) Compounds and methods for modulating splicing
RU2020123151A (ru) Антагонисты tlr7/8 и их применение
JP2016515096A (ja) スルファモイル−アリールアミドおよびb型肝炎を処置するための医薬品としてのその使用
JP2017533968A5 (cg-RX-API-DMAC7.html)
JP2007508305A5 (cg-RX-API-DMAC7.html)
JP2009534358A5 (cg-RX-API-DMAC7.html)
RU2004126671A (ru) Гетероарилсоединения, полезные в качестве ингибиторов gsk-3
JP2008503484A5 (cg-RX-API-DMAC7.html)
JP2012236838A5 (cg-RX-API-DMAC7.html)
JP2007500129A5 (cg-RX-API-DMAC7.html)
JP2016506959A5 (cg-RX-API-DMAC7.html)
JP2008509166A5 (cg-RX-API-DMAC7.html)
ES2875737T3 (es) Derivados de 2-fenil-3H-imidazo[4,5-b]piridina útiles como inhibidores de la actividad tirosina quinasa de ROR1 de mamíferos
JP2006507355A5 (cg-RX-API-DMAC7.html)
JP2009538910A5 (cg-RX-API-DMAC7.html)
JP2019527724A5 (cg-RX-API-DMAC7.html)
JP2024505571A5 (cg-RX-API-DMAC7.html)
US10947225B2 (en) Phosphotidylinositol 3-kinase inhibitors
IL295955A (en) Compounds and methods for modulating splicing